Interest of 18F-FDG Positron Emission Tomography in the Management of Fevers and Inflammatory Syndromes

Inflammation Clinical Trial

Official title:

Evaluation of the Interest of 18F-FDG Positron Emission Tomography in the Management of Unexplained Fevers and Inflammatory Syndromes in Elderly Subjects

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04001491
• Other study ID #: 7473
• Status: Not yet recruiting
• Start date: August 1, 2019
• Est. completion date: August 2020

Study information

• Verified date: June 2019
• Source: University Hospital, Strasbourg, France
• Contact: Emmanuel ANDRES, MD, PhD
• Phone: 33 3 88 11 50 66
• Email: emmanuel.andres[@]chru-strasbourg.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Patients aged 75 and over represent a heterogeneous population with fragile subjects who have a higher risk of poor tolerance to many tests and especially who have a risk of major functional loss in the event of hospitalization. It is therefore necessary to adapt our prescriptions and not to impose on these patients an examination that is unnecessary. Or on the contrary, not to do without, out of ignorance, a minimally invasive examination that could be useful to these patients.

In this study, the investigators wish to evaluate the interest of the Pet-Scan in the therapeutic management of these elderly patients

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 150
• Est. completion date: August 2020
• Est. primary completion date: August 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 75 Years and older

Eligibility

Inclusion criteria:

• Patient aged 75 years and over,

• Patients cared for at the HUS, in hospital or in consultation, during the defined period (from 01/05/2013 to 31/12/2018)

• Having had an 18FDG-PET/TDM

• For fever or inflammatory syndrome check-ups, regardless of the duration of the evolution and the examinations already carried out

• Patient who has not expressed opposition to the reuse of their data for the purposes of this research.

Exclusion criteria:

• Patient who has expressed opposition to participating in the study

• Known explanation for fever or inflammatory syndrome

• Subjects under legal protection

• Subject under the protection of justice

• Subject under guardianship or curatorship

Translated with www.DeepL.com/Translator

Related Conditions & MeSH terms

• Inflammation

Locations

Country	Name	City	State
France	Service de Médecine Interne, diabète et maladies métaboliques - Médicale B	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evaluate the interest of the Pet-Scan in the therapeutic management of subjects aged 75 years and over with unexplained fever or inflammatory syndrome.	That is, to assess whether or not the therapeutic course of action has been modified by this examination, resulting in either the discontinuation or initiation of medical, surgical or radiotherapy treatment	1 month